Back
Corporate News
JHS Svendgaard Laboratories reports deviation regarding Rs 29.99 crore preferential issue funds
11-Aug-2026, 06:23
JHS Svendgaard Laboratories Limited informed the Bombay Stock Exchange Limited and National Stock Exchange of India Limited that it has filed a statement of deviation or variation under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended June 30, 2026, regarding the utilization of Rs 29.99 crore raised through a preferential issue on June 4, 2024, with Rs 764.46 crore utilized for setting up a new project in Jammu & Kashmir, Rs 749.50 crore for general corporate purposes, and Rs 962.50 crore infused into JHS Svendgaard Retail Ventures Ltd.
JHS Svendgaard Laboratories Limited informed the Bombay Stock Exchange Limited and National Stock Exchange of India Limited that it has filed a statement of deviation or variation under Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, for the quarter ended June 30, 2026, regarding the utilization of Rs 29.99 crore raised through a preferential issue on June 4, 2024, with Rs 764.46 crore utilized for setting up a new project in Jammu & Kashmir, Rs 749.50 crore for general corporate purposes, and Rs 962.50 crore infused into JHS Svendgaard Retail Ventures Ltd.